LLY
Eli Lilly and Company
- Cash and short-term investments, 2024
- $3.4B
- YoY, 2024
- +16.9%
- 5-year CAGR
- +7.0%
- 10-year CAGR
- −3.4%
Cash and short-term investments
Cash and short-term investments by fiscal year
| Period | Cash | YoY |
|---|---|---|
| 2024 | $3.4B | +16.9% |
| 2023 | $2.9B | +32.4% |
| 2022 | $2.2B | −43.4% |
| 2021 | $3.9B | +6.2% |
| 2020 | $3.7B | +51.0% |
| 2019 | $2.4B | −67.1% |
| 2018 | $7.4B | −7.8% |
| 2017 | $8.0B | +33.0% |
| 2016 | $6.0B | +35.6% |
| 2015 | $4.5B | −7.8% |
| 2014 | $4.8B | −10.6% |
| 2013 | $5.4B | −5.0% |
| 2012 | $5.7B | −17.6% |
| 2011 | $6.9B | +2.5% |
| 2010 | $6.7B | +49.6% |
| 2009 | $4.5B | −24.1% |
| 2008 | $5.9B | — |